Multimodule characterization of immune subgroups in intrahepatic cholangiocarcinoma reveals distinct therapeutic vulnerabilities.
Lin J, Dai Y, Sang C, Song G, Xiang B, Zhang M, Dong L, Xia X, Ma J, Shen X, Ji S, Zhang S, Wang M, Fang H, Zhang X, Wang X, Zhang B, Zhou J, Fan J, Zhou H, Gao D, Gao Q.
Lin J, et al. Among authors: zhou h, zhou j.
J Immunother Cancer. 2022 Jul;10(7):e004892. doi: 10.1136/jitc-2022-004892.
J Immunother Cancer. 2022.
PMID: 35863823
Free PMC article.